Army and Air Force leadership in the Prostate Cancer Prevention Trial.

[1]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[2]  M. Barry,et al.  Controversies in Prostate Cancer Screening: Analogies to the Early Lung Cancer Screening Debate , 1996 .

[3]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  O. Sartor,et al.  A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response , 1996, Cancer Chemotherapy and Pharmacology.

[5]  J. Crowley,et al.  Design of the Prostate Cancer Prevention Trial (PCPT). , 1995, Controlled clinical trials.

[6]  G. Haas,et al.  The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. , 1993, The Journal of urology.

[7]  R. Vessella,et al.  Screening for prostatic carcinoma with prostate specific antigen: results of the second year. , 1993, The Journal of urology.

[8]  G. Andriole,et al.  The effect of finasteride in men with benign prostatic hyperplasia. , 1992, The Journal of urology.

[9]  R. Vessella,et al.  Screening for prostatic carcinoma with prostate specific antigen. , 1992, The Journal of urology.

[10]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[11]  E. Crawford,et al.  Total androgen ablation: American experience. , 1991, The Urologic clinics of North America.

[12]  D. Holt,et al.  Inhibitors of steroid 5 alpha-reductase in benign prostatic hyperplasia, male pattern baldness and acne. , 1989, Trends in pharmacological sciences.

[13]  P. Goodman,et al.  A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. , 1989, The New England journal of medicine.

[14]  H. Adami,et al.  NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.

[15]  F. Schröder,et al.  Total Androgen Blockade , 1988 .

[16]  R. E. Peterson,et al.  Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism , 1974, Science.